The Filipino FDA has proposed a shorter review time for drugs if their clinical studies are completed successfully and approved by the US FDA, PMDA, TGA, EMA, and UK/Canadian FDAs. These approvals would only apply for drugs that can help with health emergencies like infectious diseases, HIV/AIDS, cancer, or rare diseases. By doing this, the Filipino FDA hopes to expedite patient access to new drugs.
